PUF60

Poly(U)-binding-splicing factor PUF60 · Q9UHX1 · PUF60 on Sugi Atlas →

0 patent compounds predicted against PUF60, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PUF60 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1UNKNOWN
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer PHASE1SUSPENDED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Implementation of Molecular Diagnostic Pathways nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PUF60 binder may also engage these)

ProteinNameSimilarity
Q3UEB3 1.000 Q3UEB3 →
Q2HJG2 1.000 Q2HJG2 →
Q9WV25 1.000 Q9WV25 →
Q6IQE0 1.000 Q6IQE0 →
Q5R469 1.000 Q5R469 →
Q8T6B9 0.999 Q8T6B9 →
Q9N3S4 0.989 Q9N3S4 →
O14102 0.987 O14102 →
PABPC4 Polyadenylate-binding protein 4 0.985 landscape →
Q91WT8 0.983 Q91WT8 →
Q923K9 0.982 Q923K9 →
Q5YD48 0.982 Q5YD48 →
A2Q848 0.982 A2Q848 →
Q6DEY7 0.982 Q6DEY7 →
Q5R8F7 0.982 Q5R8F7 →
Q6GR16 0.982 Q6GR16 →
Q05196 0.982 Q05196 →
A4QUF0 0.981 A4QUF0 →
Q8TC92 0.981 Q8TC92 →
Q5R9H4 0.981 Q5R9H4 →
Q4WK03 0.981 Q4WK03 →
Q8BHR2 0.981 Q8BHR2 →
Q7TMK9 0.981 Q7TMK9 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.981 landscape →
Q9H361 0.980 Q9H361 →
Q9VIV2 0.980 Q9VIV2 →
Q0CR95 0.980 Q0CR95 →
Q9EPH8 0.980 Q9EPH8 →
P16914 0.980 P16914 →
Q9NQ94 0.980 Q9NQ94 →